Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Commentary

Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment

Online download statistics by month:

Online download statistics by month: July 2020 to April 2023

	Abstract	Full	Pdf
Jul 2020	305	305	127
Aug 2020	158	161	104
Sep 2020	129	129	42
Oct 2020	133	134	48
Nov 2020	73	74	34
Dec 2020	79	79	37
Jan 2021	118	119	54
Feb 2021	88	88	23
Mar 2021	127	127	44
Apr 2021	113	113	30
May 2021	71	71	28
Jun 2021	55	55	29
Jul 2021	65	66	20
Aug 2021	53	53	13
Sep 2021	60	60	16
Oct 2021	66	66	28
Nov 2021	76	75	28
Dec 2021	33	33	10
Jan 2022	49	52	12
Feb 2022	48	48	10
Mar 2022	74	78	15
Apr 2022	102	103	20
May 2022	79	79	15
Jun 2022	60	61	11
Jul 2022	68	68	12
Aug 2022	59	59	14
Sep 2022	56	59	22
Oct 2022	51	53	19
Nov 2022	45	45	4
Dec 2022	54	54	14
Jan 2023	59	59	20
Feb 2023	66	66	18
Mar 2023	36	37	10
Apr 2023	18	18	15
Total	2726	2747	946